Wang, et al. have provided new and novel evidence about the importance of using α-fetoprotein (ALP) and glypican-3 (GPC-3) mRNA detection in peripheral blood of the patients with hepatocellular carcinoma (HCC) recurrence after ortothopic liver transplantation (OLT) [1]. Here, GPC3 is linked to hepatocellular carcinoma.